These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

51 related articles for article (PubMed ID: 2887011)

  • 41. [Somatostatin].
    Radbil' OS
    Klin Med (Mosk); 1978 May; 56(5):28-34. PubMed ID: 207926
    [No Abstract]   [Full Text] [Related]  

  • 42. Somatostatin: its role in health and disease.
    Gottesman IS; Mandarino LJ; Gerich JE
    Spec Top Endocrinol Metab; 1982; 4():177-243. PubMed ID: 6134345
    [No Abstract]   [Full Text] [Related]  

  • 43. [Hypothalamic releasing hormones. I. Structure, sources of formation, physiologic effects].
    Dedov II; Dedov VI
    Usp Sovrem Biol; 1980; 89(1):141-58. PubMed ID: 6104883
    [No Abstract]   [Full Text] [Related]  

  • 44. Somatostatin and growth hormone regulation in cancer.
    Manni A
    Biotherapy; 1992; 4(1):31-6. PubMed ID: 1347453
    [TBL] [Abstract][Full Text] [Related]  

  • 45. [Possibilities of medical treatment in acromegaly].
    Cáp J; Nemecek S; Rezácová M; Cerman J
    Cas Lek Cesk; 2005; 144 Suppl 3():33-4, 36-7. PubMed ID: 16335261
    [TBL] [Abstract][Full Text] [Related]  

  • 46. The role of modulation of GH/IGF-I axis in the development of diabetic proliferative retinopathy.
    Genovese S; Riccardi G
    J Endocrinol Invest; 2003; 26(8 Suppl):114-6. PubMed ID: 15233225
    [No Abstract]   [Full Text] [Related]  

  • 47. Therapeutic applications of somatostatin and its analogue octreotide.
    Harris AG; Kokoris SP
    Eur J Med; 1993 Feb; 2(2):97-105. PubMed ID: 7903061
    [No Abstract]   [Full Text] [Related]  

  • 48. The effects of somatostatin and octreotide on experimental and human acute pancreatitis.
    Greenberg R; Haddad R; Kashtan H; Kaplan O
    J Lab Clin Med; 2000 Feb; 135(2):112-21. PubMed ID: 10695655
    [TBL] [Abstract][Full Text] [Related]  

  • 49. [Somatostatin analogues for the treatment of gastro-entero-pancreatic neuroendocrine tumours].
    Uomo G; Germano D; Rabitti PG
    Minerva Endocrinol; 2001 Dec; 26(4):225-9. PubMed ID: 11782707
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Use of somatostatin receptor ligands in obesity and diabetic complications.
    Boehm BO; Lustig RH
    Best Pract Res Clin Gastroenterol; 2002 Jun; 16(3):493-509. PubMed ID: 12079271
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Somatostatin.
    Bloom SR; Polak JM
    Br Med J (Clin Res Ed); 1987 Aug; 295(6593):288-90. PubMed ID: 2888511
    [No Abstract]   [Full Text] [Related]  

    [Previous]     [New Search]
    of 3.